PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells. - Wikidata - awgldk - TriplyDB

PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells.

PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells.

http://www.wikidata.org/entity/Q30484694

about

Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer Targeting glioma stem cells: a novel framework for brain tumors PPARγ agonists regulate the expression of stemness and differentiation genes in brain tumour stem cells Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma Combination Treatment with PPARγ Ligand and Its Specific Inhibitor GW9662 Downregulates BIS and 14-3-3 Gamma, Inhibiting Stem-Like Properties in Glioblastoma Cells.Characterization of fenofibrate-mediated anti-proliferative pro-apoptotic effects on high-grade gliomas and anti-invasive effects on glioma stem cells.Peroxisome proliferator-activated receptors and cancer: challenges and opportunities Leptin and peroxisome proliferator-activated receptor γ expression in colorectal adenoma The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cells.Changes in the expression of proteins associated with aerobic glycolysis and cell migration are involved in tumorigenic ability of two glioma cell lines Brg1 determines urothelial cell fate during ureter development BIS-mediated STAT3 stabilization regulates glioblastoma stem cell-like phenotypes.Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells PPARγ maintains ERBB2-positive breast cancer stem cells.Targeting CD133 antigen in cancer.Biological Rationale for the Use of PPARγ Agonists in Glioblastoma Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.Understanding the role of tumor stem cells in glioblastoma multiforme: a review article.Proteomics revisits the cancer metabolome.PPAR gamma, bioactive lipids, and cancer progression.Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response.Functions of neurotrophins and growth factors in neurogenesis and brain repair.MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells.Cancer stem cell markers: what is their diagnostic value?Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer.Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile.Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.Physiological and Pathological Roles of 15-Deoxy-Δ12,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases.Brain fatty acid-binding protein and omega-3/omega-6 fatty acids: mechanistic insight into malignant glioma cell migration.PPAR Could Contribute to the Pathogenesis of Hepatocellular Carcinoma.Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells.Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?Energy metabolism in glioblastoma stem cells: PPARα a metabolic adaptor to intratumoral microenvironment.Targeting glioblastoma stem cells (GSCs) with peroxisome proliferator-activated receptor gamma (PPARγ) ligands.Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer.15d-PGJ2 is a new hope for controlling tumor growth.Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas.

P2860

Q26865911-F7702043-F583-4CA0-BE1D-D3FADA706CC3 Q27026428-E9164222-F4BD-4704-B8CC-92C62F2A220D Q27026818-8AF84F9B-4653-4B8E-8657-344211F2391B Q30454765-FC84A19D-F693-4C75-A757-442774AE7091 Q33692555-93AAB907-81CF-4694-8F84-8F6C1FB17CAC Q33748280-60DB4B33-4886-4E7D-9F66-8929168B0E6B Q33794951-F7E12F31-FB4A-4B54-8665-98C8679234A9 Q34402079-C98C3647-C64C-48BC-834A-E0A6E1930B95 Q35210023-FEC8E986-3279-4B1F-A5F6-57C20B5C2D85 Q35759627-1CDE6FBB-8B2D-45D8-8068-6CD0277C22D2 Q36356318-3B8816AE-4D5D-424A-BD68-5B4EFF567449 Q36541660-456B4C40-A27A-49FD-B319-2E64AF817875 Q36719270-BF3259FC-3F46-4987-B2E1-C7F19A099563 Q37376452-BC6F9691-AE65-4D3B-8CFA-0F96B28A77A7 Q37481912-4627FE36-7D81-45D1-A663-FD75579DED46 Q37501777-D9AD9560-D2C3-4D34-AAE6-819AEAEAAE87 Q37521082-21AD8F34-50EF-4740-AD0A-3B488FC10D1F Q37636459-A086AEF7-876D-4307-BFCD-D5958B42FF35 Q37640483-AE0D7993-8DAC-42F4-84CC-3A95D6451409 Q37790294-0489B19C-93BB-432A-818A-55D4AD90809F Q37912205-DCE1F60A-94FB-4CB3-93A2-AA94A19AB9C5 Q37971590-D9C7E9D1-B82B-4346-A537-201BE84B9293 Q38039759-E037BDF6-F30A-41B0-B0F4-E21743758334 Q38050300-0FAF989C-DDE9-4781-A5FB-EF26B53112A7 Q38086010-CC7A3613-609A-45F4-BD80-80737464409D Q38089898-93BE31FC-F1D7-4638-B915-831AAA2C5F79 Q38448721-9BCA8D2C-3234-43A0-A9F3-EFA1ACC32C2F Q38790973-262913D8-AE7A-4EBF-8917-8D81AE32D32E Q39129183-64949BDD-1137-4B2B-9814-067DCFC46BBD Q39181325-C8BF3C50-F6F6-4B2D-A80E-BFF17B413650 Q41984462-B60EE9A9-CA95-4927-8F01-5D64C2318F0F Q42125206-E7C33D17-5182-4B39-84C9-C04730B1C114 Q42653228-C24DF335-43B7-47FF-8D5C-99A0DD366F2E Q42737831-457DDE52-A2C9-49B5-AC10-13C22F61EA57 Q47390152-721AF5A2-6422-44E5-BA00-CF465774C28F Q48946085-600DC2DE-FEF8-4BC9-95AE-AF560B84A8DA Q50437809-3BC8A502-4E99-498B-932C-24D334E96B41 Q52595122-B24DF7AD-ADDB-4220-9C28-14258FB970FD Q55457391-1F915FEE-1499-4007-AFA8-E0605EE67DAB

P2860

PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells.

http://www.wikidata.org/entity/Q30484694

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells.

@ast

PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells.

@en

type

label

PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells.

@ast

PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells.

@en

prefLabel

PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells.

@ast

PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells.

@en

P1433

Q30484694-AECC4473-A0E1-4D0C-95F9-9DA5AE6B7999

P1476

Q30484694-8F3C6C16-6B12-49BC-B979-C7E35644C534

P2093

Q30484694-D921CDEF-C67C-497A-A498-B4B0589FB254

Q30484694-E34A517F-A19C-4CCB-BA64-3DE985331D63

P2860

Q30484694-0B69D9A0-121B-4CB8-84B2-D8C78DF42A46

Q30484694-0FB1C2FF-0872-4668-9D07-1C8C52C059EC

Q30484694-10B8A3A5-DBE8-4C49-95B8-1E7766EEF3CE

Q30484694-121392F5-5247-4295-AE9F-A0742DF7C567

Q30484694-166BC9D6-EB5B-47BA-96FF-1F98F828DA51

Q30484694-306A6027-31A2-4D56-B6C4-8BE22AE11523

Q30484694-33DE8868-1746-4DDA-A741-90D87FCA5434

Q30484694-361A2C38-077A-4794-BB18-1DFEA01174AC

Q30484694-363B231D-139B-456C-AE04-CAED0F998D47

Q30484694-404E1A34-187D-4FA7-A7A1-CC967AF85FB8

P2888

Q30484694-A5617098-0BAA-4371-8EDE-C5B36F0CFA7D

P304

Q30484694-C89349E0-5F2D-416B-BCB6-3CC8EFBE4A80

P31

Q30484694-49620532-EF86-49BF-98F0-E4159D562BB2

P356

Q30484694-627EB52B-F771-474F-9AD5-C046287253AE

P407

Q30484694-D5B711E4-86D3-4C6C-8BBA-B2D3B0023D63

P433

Q30484694-8FFFDBED-A5BB-40DE-81B4-A8CA91835720

P478

Q30484694-6A379F98-C334-4AC6-83E8-030CA5B7FD6B

P577

Q30484694-F26E45BA-15A0-42E6-8D0B-E8839B53F4E2

P5875

Q30484694-259FE27E-AB1B-42AA-9169-AA7C5F22AC38

P6179

Q30484694-BECBB28A-8071-4217-9A77-6D5C6A7490D8

P698

Q30484694-8FC173DF-2482-4B55-A19E-5513DD8AF956

P932

Q30484694-4EF0E76C-C998-4018-B27C-67264DE2CDE3

P356

P1433

British Journal of Cancer

P1476

PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells.

@en

P2093

J J Bright

http://www.w3.org/2001/XMLSchema#string

W Chearwae

http://www.w3.org/2001/XMLSchema#string

P2860

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Identification of human brain tumour initiating cells

Fibroblast growth factors as multifunctional signaling factors

Direct isolation of human central nervous system stem cells

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

The search for neural progenitor cells: prospects for the therapy of neurodegenerative disease.

From neural stem cells to myelinating oligodendrocytes.

P2888

P304

2044-2053

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6604786

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23482480

http://www.w3.org/2001/XMLSchema#string

P6179

1005392840

http://www.w3.org/2001/XMLSchema#string

P698

19018263

http://www.w3.org/2001/XMLSchema#string

P932

2607234

http://www.w3.org/2001/XMLSchema#string